Report
Oscar Haffen Lamm ...
  • Valliant Campagne

Aelis: AEF0217 phase 1/2 on track to readout in Q4 2024

Aelis reported its H1 2024 financial results with a cash position of EUR 12.6m, excl. EUR 4.5m raised late July which provide a runway until YE 2026. On the back of the phase 2b readout, which primary endpoint (proportion of patients using cannabis ≤ 1 day per week) wasn't met, further analysis on
Underlying
AELIS FARMA SA

Provider
Bryan Garnier
Bryan Garnier

Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.

Analysts
Oscar Haffen Lamm

Valliant Campagne

Other Reports on these Companies
Other Reports from Bryan Garnier

ResearchPool Subscriptions

Get the most out of your insights

Get in touch